Banka BioLoo Q1 FY27 results: Standalone PAT down, Consolidated turns to loss
BANKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Banka BioLoo reported Q1 FY27 results for the quarter ended 30 June 2026. Standalone revenue from operations fell sharply to Rs. 1,635.78 lakhs from Rs. 5,975.76 lakhs YoY. Standalone PAT dropped to Rs. 37.13 lakhs vs Rs. 135.54 lakhs. Consolidated PAT swung to a loss of Rs. 3.93 lakhs vs Rs. 0.21 lakhs profit. Auditor flagged an Emphasis of Matter on Rs. 738.61 lakhs of trade receivables from government bodies (CDMA and Swachha Andhra Corporation). Board also approved re-appointment of MD Namita Banka, granted 16,000 ESOPs at face value, and fixed the 14th AGM for 17 September 2026.
Sharp revenue drop and consolidated loss mark a weak quarter. Emphasis on large government receivables keeps recovery risk in focus. Watch order inflows.